Why Is AMRIZE LTD (AMRZ) Stock Down Today?

AMRZ stock fell 8.94% to $46.64 on Monday, driven by RBC Capital cutting its rating on the stock following a Q2 earnings miss and a revised guidance. The move came amid broader market weakness and mixed earnings results from other major firms. The stock has declined 4.7% over the past eight sessions, extending its downward trend from a 52-week high of $65.94.

What Happened

RBC Capital downgraded Amrize following its Q2 earnings report, which showed adjusted earnings per share of $0.88, below the $0.94 estimate. While the company reported revenue of $3.494 billion, beating the $3.365 billion estimate, it cited rising costs for freight, diesel, and raw materials as headwinds. The firm also cut its full-year guidance and announced a modest sales increase for FY2026. Oppenheimer maintained its Outperform rating but lowered its price target to $65. Meanwhile, Amrize disclosed an agreement to acquire Rapid Redi-Mix, though terms were not disclosed.

What The Data Shows

Amrize has a market cap of $28.5 billion and a P/E ratio of 20.9. The stock has traded between $44.12 and $65.94 over the past 52 weeks. Recent insider activity has been positive, with five separate buys totaling $2.7 million reported in the last 90 days. Congressional activity also showed a single purchase between $1,001 and $15,000. Despite the earnings miss, the company raised its FY2026 sales guidance to $12.5 billion to $12.7 billion.

What To Watch

Amrize has no scheduled earnings date in the immediate future, but investors will be watching for additional analyst commentary and coverage breadth to gauge the market’s reaction to the guidance cut and earnings performance.